Category: Approval/Launch Region: North America · United States Company: Argenx Us Inc

Japans MHLW approves argenxs Vyvgart to treat generalized myasthenia gravis

Japans MHLW approves argenxs Vyvgart to treat generalized myasthenia gravis
argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that Japan

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!